47 results
Page 2 of 3
8-K
EX-99.2
f23lb
3 Oct 23
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
4:16pm
8-K
EX-99.1
13kdv50
3 Oct 23
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
4:16pm
8-K
EX-99.1
egdl a7fjd
28 Sep 23
Regulation FD Disclosure
11:27am
8-K
EX-99.1
6vlat
26 Sep 23
Signed term sheet providing for up to $75 Million in debt financing to be used for the acquisition
8:45am
424B4
qpiw816qiv6
25 Apr 23
Prospectus supplement with pricing info
4:15pm
10-K
1a4rno418 0w2
31 Mar 23
Annual report
4:17pm
8-K
EX-99.1
wkydtwk17xpag2 7qq8
20 Dec 22
Sharps Technology Begins Manufacturing at its Hungary Facility for the Company’s Innovative Syringe Products
8:20am
8-K
EX-99.1
z9sa3xmh
13 Dec 22
Sharps Technology and Nephron Pharmaceuticals Signs Distribution
8:45am
8-K
EX-99.1
qfaf62fhu8yq45c1uqi
10 Nov 22
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce
4:06pm
8-K
EX-99.1
1hc94 b8krbhal
14 Jul 22
Sharps Technology Completes Acquisition of Safegard Medical Syringe Manufacturing Facility
4:05pm
8-K
EX-99.1
vbwtp udy3aa9
8 Jun 22
Sharps Technology Announces Letter to Shareholders
4:10pm
10-Q
1vjphuc4
25 May 22
Quarterly report
5:29pm
8-K
EX-99.2
zk5mv1
19 Apr 22
Sharps Technology Announces Pricing of Initial Public Offering
4:17pm